March 15, 2010 (Chinavestor) Shares of American Oriental Bioengineering Inc. (NYSE:AOB) fell -8.97% by 2:24 P.M. on Monday following 2009 fourth quarter and full year earnings report. Most of the fall is due to a worse-than-expected bottom line and lowered earnings guidance.
As the following chart suggests, analysts were expecting EPS of $.17 - $.19 vs. actual of $.13. And if it wasn't bad enough, profit outlook for the company is below current numbers.
Source: Reuters.com
Taking a look at top and bottom line growth, our favorite method of a speedy yet meaningful analysis, reveals that share price of American Oriental Bioengineering (NYSE:AOB) is in-line with current earning, but is way above future earnings. Considering the -8.7% drop in share price for today, investors are buying time to see where the company is going. One thing is for sure: high volatility is here to say.
March 2, 2010 (Chinavestor) Chinese medical equipment developer, manufacturer and marketer Mindray Medical (NYSE:MR) reported 2009 full year and fourth quarter financial result after the close yester...
Feb. 13, 2010 (Chinavestor) Investing 101 says earnings and revenue growth are driving stock prices for the long haul. Let's take a look at 3SBio Inc. (NASDAQ:SSRX) keeping this simple yet often ov...
(Sept. 2, 2009 - Zou Soueidan) It's about that time of year again. After a lull in the immediate public concern over a swine flu outbreak, the media has once again made us aware that a potential epide...
(Sept. 2, 2009) It appears that investors are beginning to take notice of Lotus Pharmaceuticals (OTC:LTUS). The GeoTeam has been tracking LTUS with some trepidation, due in part to the following is...
-->